1	Varón	varón	NCMS000	C0086582	hallazgo#estructura_corporal	0-5	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	de	de	SPS00	C0332285	atributo	6-8	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	54	54		-	-	9-11	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	con	con	SPS00	C0332287	atributo	17-20	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	persistencia	persistencia	NCFS000	C0546816	hallazgo	21-33	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
7	de	de	SPS00	C0332285	atributo	34-36	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
8	cifras	cifra	NCFP000	-	-	37-43	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
9	altas	alto	AQ0FP0	C0205250	calificador	44-49	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
10	de	de	SPS00	C0332285	atributo	50-52	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
11	colesterol	colesterol	NCMS000	C0008377	sustancia	53-63	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
12	a	a	SPS00	-	-	64-65	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
13	pesar	pesar	VMN0000	C1879338#C0018235	hallazgo	66-71	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
14	de	de	SPS00	C0332285	atributo	72-74	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
15	recibir	recibir	VMN0000	-	-	75-82	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
16	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	83-94	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
17	con	con	SPS00	C0332287	atributo	95-98	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
18	atorvastatina	atorvastatina	NC00SC0	C0286651	producto#sustancia	99-112	768_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
19	40	40	Z	-	-	113-115	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
20	mg	mg	NCMN000	-	-	116-118	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
21	(	(	Fpa	-	-	119-120	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
22	no	no	RN	C1298908	calificador	120-122	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
23	toleró	tolerar	VMIS3S0	-	-	123-129	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
24	la	el	DA0FS0	-	-	130-132	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
25	dosis	dosis	NCFN000	-	-	133-138	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
26	de	de	SPS00	C0332285	atributo	139-141	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
27	80	80	Z	-	-	142-144	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
28	mg	mg	NCMN000	-	-	145-147	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
29	por	por	SPS00	C0678226	atributo	148-151	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
30	mialgias	mialgia	NCFP000	C0231528	hallazgo	152-160	768_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
31	)	)	Fpt	-	-	160-161	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
32	y	y	CC	C1706368	calificador	162-163	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
33	haber	haber	VAN0000	-	-	164-169	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
34	asociado	asociar	VMP00SM	-	-	170-178	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
35	ezetimiba	ezetimiba	NC00BO0	-	-	179-188	768_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
36	.	.	Fp	-	-	188-189	768_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	No	no	RN	C1298908	calificador	190-192	768_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	refiere	referir	VMIP3S0	-	-	193-200	768_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	antecedentes	antecedente	NCMP000	C0332119_1	situación_1	201-213	768_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	de	de	SPS00	C0332119_2	situación_2	214-216	768_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	hipertensión	hipertensión	NCFS000	C0020538_1	trastorno_1	217-229	768_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	Negacion	-	-	-
6	arterial	arterial	NC00SC0	C0020538_2	trastorno_2	230-238	768_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-	5	3780	LOC
7	ni	ni	CC	-	-	239-241	768_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
8	diabetes	diabetes	NCFN000	-	-	242-250	768_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	Negacion	-	-	-
9	.	.	Fp	-	-	250-251	768_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	Aporta	aportar	VMIP3S0	-	-	252-258	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	analítica	analítica	NCFS000	-	-	259-268	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	reciente	reciente	AQ0CS0	C0332185	calificador	269-277	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	con	con	SPS00	C0332287	atributo	278-281	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
5	los	el	DA0MP0	-	-	282-285	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
6	siguientes	siguiente	AQ0CP0	C0332282	atributo	286-296	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
7	resultados	resultado	NCMP000	C1704419#C1280500#C1280519#C1274040	concepto_para_navegación	297-307	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
8	:	:	Fd	-	-	307-308	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
9	colesterol	colesterol	NCMS000	C0543421_1	sustancia_1	309-319	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
10	total	total	NCMS000	C0543421_2	sustancia_2	320-325	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
11	302	302	Z	-	-	326-329	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
12	mg	mg	NCMN000	-	-	330-332	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
13	/	/	Fh	-	-	332-333	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
14	dl	decilitro	NCMN000	C0439241	calificador	333-335	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
15	,	,	Fc	-	-	335-336	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
16	LDL-colesterol	ldl-colesterol	NCMS000	-	-	337-351	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
17	270	270	Z	-	-	352-355	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
18	mg	mg	NCMN000	-	-	356-358	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
19	/	/	Fh	-	-	358-359	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
20	dl	decilitro	NCMN000	C0439241	calificador	359-361	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
21	,	,	Fc	-	-	361-362	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
22	HDL-colesterol	hdl-colesterol	NCMS000	-	-	363-377	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
23	32	32	Z	-	-	378-380	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
24	mg	mg	NCMN000	-	-	381-383	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
25	/	/	Fh	-	-	383-384	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
26	dl	decilitro	NCMN000	C0439241	calificador	384-386	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
27	y	y	CC	C1706368	calificador	387-388	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
28	triglicéridos	triglicérido	NCMP000	C0041004#C0392693	sustancia	389-402	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
29	normales	normal	AQ0CP0	C0205307	calificador	403-411	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
30	.	.	Fp	-	-	411-412	768_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

1	Destaca	destacar	VMIP3S0	-	-	413-420	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
2	en	en	SPS00	C1720294#C0332285	calificador#atributo	421-423	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
3	la	el	DA0FS0	-	-	424-426	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
4	exploración	exploración	NCFS000	C0031809_1	procedimiento_1	427-438	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
5	física	físico	NCFS000	C0031809_2	procedimiento_2	439-445	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
6	un	un		C0205447_1	calificador_1	446-448	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
7	IMC	imc	NC00SC0	C1305855	entidad_observable	449-452	768_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-	-	-	-
8	de	de	SPS00	C0332285	atributo	453-455	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
9	29	29		-	-	456-458	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
10	y	y	CC	C1706368	calificador	459-460	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
11	un	un		C0205447_1	calificador_1	461-463	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
12	engrosamiento	engrosamiento	NCMS000	C0205400	hallazgo	464-477	768_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-	-	-	-
13	a	a	SPS00	-	-	478-479	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
14	nivel	nivel	NCMS000	C0456079	atributo	480-485	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
15	de	de	SPS00	C0332285	atributo	486-488	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
16	los	el	DA0MP0	-	-	489-492	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
17	tendones	tendón	NCMP000	C1280538#C0039508	estructura_corporal	493-501	768_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-	12	3782	LOC
18	de	de	SPS00	C0332285	atributo	502-504	768_QUEST_clinical_caseMIR	SENT4	I-Estructura_Corporal	-	17	7	MultiE
19	Aquiles	aquiles	NCMP000	-	-	505-512	768_QUEST_clinical_caseMIR	SENT4	I-Estructura_Corporal	-	17	7	MultiE
20	.	.	Fp	-	-	512-513	768_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-

